Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0035 | 0.082 | 0.2803 |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0229 | 0.7055 | 0.8958 |
Brugia malayi | AMP-binding enzyme family protein | 0.0028 | 0.0601 | 0.1122 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0021 | 0.0374 | 0.1279 |
Echinococcus granulosus | dihydrolipoamide dehydrogenase | 0.0035 | 0.082 | 0.1531 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0374 | 0.0698 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0035 | 0.082 | 0.2803 |
Trypanosoma brucei | trypanothione reductase | 0.01 | 0.2926 | 1 |
Loa Loa (eye worm) | glutathione reductase | 0.01 | 0.2926 | 0.546 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0035 | 0.082 | 0.2803 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.0022 | 0.0416 | 0.142 |
Toxoplasma gondii | thioredoxin reductase | 0.01 | 0.2926 | 1 |
Mycobacterium ulcerans | flavoprotein disulfide reductase | 0.0035 | 0.082 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0028 | 0.0601 | 0.733 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0601 | 0.1122 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0101 | 0.2945 | 0.5496 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.0022 | 0.0416 | 0.142 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase | 0.0035 | 0.082 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0176 | 0.536 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0022 | 0.0416 | 0.5067 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0022 | 0.0416 | 0.5067 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD3 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.002 | 0.0338 | 0.0429 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0022 | 0.0416 | 0.6913 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, apicoplast, putative | 0.0035 | 0.082 | 0.2803 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0028 | 0.0601 | 0.2055 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0028 | 0.0601 | 0.2055 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0021 | 0.0374 | 0.1279 |
Trichomonas vaginalis | glutathione reductase, putative | 0.0035 | 0.082 | 1 |
Chlamydia trachomatis | dihydrolipoyl dehydrogenase | 0.0035 | 0.082 | 1 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0229 | 0.7055 | 0.8958 |
Brugia malayi | AMP-binding enzyme family protein | 0.0028 | 0.0601 | 0.1122 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0022 | 0.0416 | 0.5067 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0035 | 0.082 | 0.2803 |
Echinococcus multilocularis | muscleblind protein | 0.0176 | 0.536 | 1 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0021 | 0.0374 | 0.4563 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.0022 | 0.0416 | 0.142 |
Brugia malayi | Thioredoxin reductase | 0.01 | 0.2926 | 0.546 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0601 | 0.1122 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0035 | 0.082 | 0.2803 |
Brugia malayi | AMP-binding enzyme family protein | 0.0028 | 0.0601 | 0.1122 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD5 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.002 | 0.0338 | 0.0429 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0021 | 0.0374 | 0.0475 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0028 | 0.0601 | 0.733 |
Toxoplasma gondii | pyruvate dehydrogenase complex subunit PDH-E3II | 0.0035 | 0.082 | 0.2803 |
Plasmodium falciparum | thioredoxin reductase | 0.0035 | 0.082 | 0.2803 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, mitochondrial | 0.0035 | 0.082 | 0.2803 |
Leishmania major | acetoin dehydrogenase e3 component-like protein | 0.0035 | 0.082 | 0.2803 |
Brugia malayi | alpha keto acid dehydrogenase complex, E3 component, lipoamide dehydrogenase | 0.0026 | 0.0524 | 0.0978 |
Plasmodium falciparum | glutathione reductase | 0.01 | 0.2926 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0022 | 0.0416 | 0.5067 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase, point mutation | 0.0035 | 0.082 | 0.2803 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0035 | 0.082 | 0.2803 |
Trichomonas vaginalis | mercuric reductase, putative | 0.0035 | 0.082 | 1 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0229 | 0.7055 | 0.8958 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0022 | 0.0416 | 0.142 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD35 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.002 | 0.0338 | 0.0429 |
Plasmodium vivax | dihydrolipoyl dehydrogenase, mitochondrial, putative | 0.0035 | 0.082 | 0.2803 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0035 | 0.082 | 0.2803 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0035 | 0.082 | 1 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0229 | 0.7055 | 0.8958 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0028 | 0.0601 | 0.733 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0028 | 0.0601 | 0.733 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0254 | 0.7875 | 1 |
Plasmodium falciparum | thioredoxin reductase | 0.01 | 0.2926 | 1 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0021 | 0.0374 | 0.4563 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0028 | 0.0601 | 0.733 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.01 | 0.2926 | 0.3716 |
Trypanosoma cruzi | dihydrolipoyl dehydrogenase, putative | 0.0035 | 0.082 | 0.2803 |
Brugia malayi | dihydrolipoyl dehydrogenase, mitochondrial precursor, putative | 0.0035 | 0.082 | 0.1531 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0028 | 0.0601 | 1 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.01 | 0.2926 | 1 |
Trypanosoma brucei | dihydrolipoyl dehydrogenase | 0.0035 | 0.082 | 0.2803 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0254 | 0.7875 | 1 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0028 | 0.0601 | 0.2055 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.0022 | 0.0416 | 0.142 |
Brugia malayi | Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain containing protein | 0.0026 | 0.0524 | 0.0978 |
Brugia malayi | glutathione reductase | 0.01 | 0.2926 | 0.546 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0022 | 0.0416 | 0.5067 |
Echinococcus multilocularis | dihydrolipoamide dehydrogenase | 0.0035 | 0.082 | 0.1531 |
Plasmodium vivax | thioredoxin reductase, putative | 0.01 | 0.2926 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.01 | 0.2926 | 1 |
Giardia lamblia | NADH oxidase lateral transfer candidate | 0.0035 | 0.082 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0022 | 0.0416 | 0.0776 |
Brugia malayi | Muscleblind-like protein | 0.0176 | 0.536 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0374 | 0.0698 |
Mycobacterium tuberculosis | Probable soluble pyridine nucleotide transhydrogenase SthA (STH) (NAD(P)(+) transhydrogenase [B-specific]) (nicotinamide nucleot | 0.0035 | 0.082 | 0.1042 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0028 | 0.0601 | 0.0763 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0028 | 0.0601 | 0.0763 |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0035 | 0.082 | 0.2803 |
Loa Loa (eye worm) | hypothetical protein | 0.0176 | 0.536 | 1 |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0229 | 0.7055 | 0.8958 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0022 | 0.0416 | 0.0528 |
Loa Loa (eye worm) | thioredoxin reductase | 0.01 | 0.2926 | 0.546 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0374 | 0.0698 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0035 | 0.082 | 0.2803 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0254 | 0.7875 | 1 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0028 | 0.0601 | 0.0763 |
Schistosoma mansoni | ap endonuclease | 0.0022 | 0.0416 | 0.0416 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0254 | 0.7875 | 1 |
Toxoplasma gondii | exonuclease III APE | 0.0022 | 0.0416 | 0.142 |
Leishmania major | 2-oxoglutarate dehydrogenase, e3 component, lipoamidedehydrogenase-like protein | 0.0035 | 0.082 | 0.2803 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0028 | 0.0601 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0374 | 0.0698 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0028 | 0.0601 | 0.733 |
Schistosoma mansoni | dihydrolipoamide dehydrogenase | 0.0035 | 0.082 | 0.082 |
Plasmodium falciparum | dihydrolipoyl dehydrogenase, apicoplast | 0.0035 | 0.082 | 0.2803 |
Leishmania major | trypanothione reductase | 0.01 | 0.2926 | 1 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0028 | 0.0601 | 1 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0022 | 0.0416 | 0.0776 |
Mycobacterium tuberculosis | Probable reductase | 0.0229 | 0.7055 | 0.8958 |
Plasmodium falciparum | glutathione reductase | 0.0035 | 0.082 | 0.2803 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0022 | 0.0416 | 0.142 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0022 | 0.0416 | 0.0776 |
Echinococcus granulosus | muscleblind protein | 0.0176 | 0.536 | 1 |
Onchocerca volvulus | 0.0028 | 0.0601 | 1 | |
Leishmania major | dihydrolipoamide dehydrogenase, putative | 0.0035 | 0.082 | 0.2803 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0374 | 0.0698 |
Trypanosoma cruzi | dihydrolipoamide dehydrogenase, putative | 0.0035 | 0.082 | 0.2803 |
Toxoplasma gondii | NADPH-glutathione reductase | 0.0035 | 0.082 | 0.2803 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0028 | 0.0601 | 0.0763 |
Wolbachia endosymbiont of Brugia malayi | dihydrolipoamide dehydrogenase E3 component | 0.0035 | 0.082 | 1 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0022 | 0.0416 | 0.5067 |
Treponema pallidum | NADH oxidase | 0.0035 | 0.082 | 1 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0176 | 0.536 | 1 |
Mycobacterium ulcerans | dihydrolipoamide dehydrogenase, LpdB | 0.0035 | 0.082 | 1 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0229 | 0.7055 | 0.8958 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD7 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.002 | 0.0338 | 0.0429 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0028 | 0.0601 | 0.733 |
Trypanosoma brucei | dihydrolipoamide dehydrogenase | 0.0035 | 0.082 | 0.2803 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0101 | 0.2945 | 0.5496 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.0601 | 0.1122 |
Schistosoma mansoni | ap endonuclease | 0.0022 | 0.0416 | 0.0416 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0022 | 0.0416 | 0.0776 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0028 | 0.0601 | 0.733 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -5.796 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.306 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -5.056 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.65 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.562 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.419 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.392 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.